The Global Multiple Sclerosis (MS) Therapies Market was valued at $22.99 billion in 2018, and is projected to reach $28.00 billion by 2027, registering a CAGR of 2% from 2021 to 2027. Multiple sclerosis (MS) refers to a chronic inflammatory immune-mediated condition that can cause demyelination, axonal amputation, and neurodegeneration of nerve cells in the […]
